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RETROSPECTIVE
BRIEF ARTICLE
STUDY

Diabetes mellitus increases risk for colorectal adenomas in
younger patients
Hongha T Vu, Nneka Ufere, Yan Yan, Jean S Wang, Dayna S Early, Jill E Elwing
ing for date of exam and gender. ADR was 14.4% in
those ages 40-49 years without DM, 30.4% in those
ages 40-49 years with DM, and 32.0% in those ages
50-59 years without DM. Compared to those ages
40-49 years without DM, ADR was higher in those ages
40-49 years with DM (OR = 3.1; 95%CI: 1.5-6.4; P =
0.002) and those ages 50-59 years without DM (OR =
2.9; 95%CI: 1.5-5.6; P = 0.002). There was no difference between the ADR in those ages 40-49 years with
DM and those ages 50-59 years without DM (P = 0.83).
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CONCLUSION: DM was associated with higher risk
of colorectal adenomas in patients ages 40-49 years.
These subjects harbored as many adenomas as those
at the standard screening age of 50-59 years without
DM.
© 2014 Baishideng Publishing Group Inc. All rights reserved.
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Abstract
AIM: To determine if diabetes mellitus (DM) is associated with increased risk of colorectal adenomas in
younger subjects.

Core tip: Diabetes mellitus (DM) is associated with increased risk of colorectal neoplasia. It is unknown if patients with DM should be screened more aggressively.
Three cohorts were compared: patients aged 40-49
years with DM, 40-49 years without DM, and 50-59
years without DM. DM was associated with increased
risk for developing colorectal adenomas in patients
40-49 years old. This is the first study to specifically examine these differences among patients with or without
DM younger than the recommended colorectal cancer
screening age of 50 years.

METHODS: This was a retrospective cohort study of
375 patients undergoing index colonoscopy at a single
tertiary care center in the United States. Three cohorts
of patients matched for exam date and gender were
compared: (1) ages 40-49 years with DM; (2) ages
40-49 years without DM; and (3) ages 50-59 years
without DM. Data collected included demographics,
co-morbidities, colonoscopy and pathology results.
Adenoma detection rates (ADR) were calculated and
compared. Conditional logistic regression analysis was
performed to determine the association between each
cohort and ADR.

Vu HT, Ufere N, Yan Y, Wang JS, Early DS, Elwing JE. Diabetes
mellitus increases risk for colorectal adenomas in younger patients. World J Gastroenterol 2014; 20(22): 6946-6952 Available
from: URL: http://www.wjgnet.com/1007-9327/full/v20/
i22/6946.htm DOI: http://dx.doi.org/10.3748/wjg.v20.i22.6946

RESULTS: One hundred and twenty-five patients ages
40-49 with DM met study eligibility criteria. Patients in
the other two cohorts were randomly selected, match-
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years with DM; and (3) ages 50-59 years without DM.
Subjects were identified from an endoscopy database
among patients undergoing index colonoscopies at Washington University in St. Louis, Missouri between June 1,
2005 and June 30, 2011. Medical records were reviewed
to determine DM status. All patients ages 40-49 years
with DM undergoing index colonoscopies within the
study period were first identified. Patients in the other
two cohorts were then randomly selected in a 1:1 ratio,
matching for date of exam and gender. Inclusion criteria also included index (first) colonoscopy, colonoscopy
completed to the cecum, and excellent or good bowel
preparation. Exclusion criteria included incomplete
colonoscopy, poor or fair bowel preparation, history of
prior colonoscopy, inflammatory bowel disease, polyposis
syndrome, prior colectomy, personal history of CRC, or
family history of CRC in a first-degree relative.
Medical records were reviewed to obtain data on demographics including age, gender, ethnicity, and height
and weight to determine body mass index (BMI). Presence or absence of DM was determined by medical history obtained by nurses at the time of colonoscopy and
corroborated by review of medical records and medication lists. DM status was also reviewed in terms of type
of diabetic medication used and hemoglobin A1C level
(HgbA1C) as a marker of glycemic control. Co-morbidities including presence of hypertension, hyperlipidemia,
tobacco use, and alcohol use were also recorded. Family history of CRC was determined by medical history
obtained by nurses and interview by colonoscopist at
the time of colonoscopy and corroborated by review
of medical records. Colonoscopy and pathology reports
were reviewed to obtain data on indication, bowel preparation quality, completeness of procedure to cecum, and
polyp characteristics (number, location, size, and pathology). Histopathologic diagnoses were recorded; high risk
state was defined as adenoma size ≥ 1 cm, number of
adenomas ≥ 3, villous features, or high grade dysplasia.
If multiple polyps were placed in the same specimen container, then pathology reports were closely reviewed to
ascertain correct histopathologic diagnosis of each polyp.
Polyp and adenoma detection rates (ADR), defined as
the proportion of screened subjects in whom at least one
polyp or adenoma was identified respectively, were calculated for each cohort.

INTRODUCTION
Colorectal cancer (CRC) is the third most common cancer affecting both men and women and second most
common cause of cancer death in the United States. In
2011, there were an estimated 141000 new diagnoses of
CRC and 49000 deaths associated with CRC[1]. There
has been a decline in the incidence of CRC over the past
two decades, which has been attributed to screening by
colonoscopy, and removal of pre-malignant colon polyps.
The United States Preventive Services Task Force. MultiSociety Task Force, and American College of Gastroenterology guidelines recommend initiating CRC screening
at 50 years of age for those at average risk, and earlier
for those at increased risk, such as those with family
history[2-4]. The American College of Gastroenterology
guidelines also recommend earlier screening in AfricanAmericans and awareness of increased risk of CRC in
patients with obesity and history of smoking[4].
Diabetes mellitus type 2 (DM) has been found to be
associated with a 20%-60% increased risk of CRC[5,6].
It is postulated that insulin resistance and the resulting
hyperinsulinemia may promote carcinogenesis directly
by stimulating colonic cell growth[7,8]. In addition, insulin
is thought to act indirectly by up-regulating growth hormone receptors in the liver to increase levels of insulinlike growth factor (IGF)-1 and inhibiting IGF binding
proteins which also results in elevated levels of free
IGF-1[7,8]. IGF-1 is theorized to then enhance cell proliferation and inhibit apoptosis, thus promoting tumor
growth. Insulin and IGF-1 may also act through Ras activation which leads to increased sensitivity to growth factors in colonic cells and possible accelerated progression
from adenoma to carcinoma[7,8]. Observational studies
have shown an increased CRC risk with hyperinsulinemia
as well as with elevated IGF-1 levels[9]. In addition, there
have been data showing a similar association with adenomatous polyps, the precursor to CRC[10-13].
There currently are no modifications in CRC screening guidelines for people with DM. In particular, it is
unknown if patients with DM should be screened earlier than patients at average risk for CRC. The aim of
this study was to determine if DM is associated with
increased risk of developing colorectal adenomas in subjects ages 40-49 years compared to an age matched group
without DM and to average risk non-diabetics at the standard screening age of 50 years or older. Our hypothesis
was that patients with DM would have increased rates of
adenomas compared to those without DM.

Statistical analysis
Statistical analyses include comparisons of patient demographics and clinical characteristics among the three
cohorts and use regression models to determine association of group status with ADR, adjusting for patient demographics and clinical characteristics. ANOVA was used
to compare continuous variables (age, body mass index)
among the three cohorts, and χ 2 test or Fisher exact test
was used to compare categorical variables (gender, ethnicity, hypertension, hyperlipidemia, indication) among the
three groups. For regression analyses, conditional logistic
regression model was used since the patients in different
cohorts were matched by date of exam and gender. Con-

MATERIALS AND METHODS
The study was approved by the Washington University
Institutional Review Board and Siteman Cancer Center
Protocol Review and Monitoring Committee. We performed a retrospective cohort study of patients undergoing colonoscopy at a single center over a six-year period,
comparing three cohorts matched for date of exam and
gender: (1) ages 40-49 years without DM; (2) ages 40-49
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Table 1 Baseline characteristics
40-49 yr without DM (n = 125)

40-49 yr with DM (n = 125)

50-59 yr without DM (n = 125)

P -value

45.7 ± 3.1
63.2
35.2
29.6 ± 7.4

46.1 ± 2.7
63.2
46.0
36.0 ± 9.6

53.7 ± 2.7
63.2
39.2
28.6 ± 7.0

< 0.001
1.0
0.13
< 0.001

40.8
16.9

76.6
50.0

46.8
25.0

< 0.001
< 0.001

15.3
41.9
29.8
6.5
2.4

14.8
45.9
30.3
3.3
3.3

83.2
7.2
5.6
1.6
1.6

< 0.001
< 0.001
< 0.001
0.13
0.69

Age (yr, mean ± SD)
Gender (% Female)
Ethnicity (% African-American)
Body mass index
(kg/m2, mean ± SD)
Hypertension (%)
Hyperlipidemia (%)
Indication (%)
Screening
Gastrointestinal bleeding
Change in bowel habits
Abdominal pain
Other
DM: Diabetes mellitus.

ditional logistic regression analysis was performed to determine the association between each cohort and ADR.
Variables included in the conditional logistic regression
model for adjustment were ethnicity, BMI, tobacco, and
alcohol. Sensitivity analyses after further allowances for
hypertension and hyperlipidemia were also performed.
Data analyses were performed by using SAS software
version 9.2 (Cary, North Carolina, United States).

in their late forties close to the recommended age of 50
years to start CRC screening. All other colonoscopies
were performed for diagnostic purposes including gastrointestinal bleeding, change in bowel habits, or abdominal
pain.
Polyp and adenoma detection rates
The polyp and adenoma detection rates are found in
Table 2. The ADRs were 14.4% in those ages 40-49 years
without DM (17.4% in men, 12.7% in women), 30.4% in
those ages 40-49 years with DM (39.1% in men, 25.3%
in women), and 32.0% in those ages 50-59 years without
DM (41.3% in men, 26.6% in women). Compared to
those ages 40-49 years without DM, there was a statistically significant higher association between cohort and
presence of adenoma in those ages 40-49 years with DM
(adjusted OR = 2.6, 95%CI: 1.4-4.9; adjusted OR=3.1,
95%CI: 1.5-6.4; P = 0.002) and those ages 50-59 years
without DM (adjusted OR = 2.8, 95%CI: 1.5-5.2; adjusted OR = 2.9, 95%CI: 1.5-5.6; P = 0.002) in both univariate and multivariate analyses. A slightly stronger association was found in men (adjusted OR = 4.7 in patients
ages 40-49 years with DM, adjusted OR = 4.0 in those
ages 50-59 years without DM) than in women (adjusted
OR = 2.5 in patients ages 40-49 years with DM, adjusted
OR = 3.3 in those ages 50-59 years without DM). Despite differences in terms of prevalence of hypertension
and hyperlipidemia between the two younger cohorts,
sensitivity analyses after further allowances for the two
co-morbidities showed a similar significant association
(OR = 3.2, 95%CI: 1.5-7.1) for patients ages 40-49 years
with DM and (OR = 3.0; 95%CI: 1.5-5.9) for those ages
50-59 without DM. There was no statistically significant
difference between cohort and presence of adenoma in
those ages 40-49 years with DM and those ages 50-59
years without DM (P = 0.78 on univariate analysis and P
= 0.83 on multivariate analysis).

RESULTS
A total of 3749 patients between the ages of 40-49 years
underwent index colonoscopy between June 2005 and
June 2011. After manual review of medical records, we
found that 193 patients ages 40-49 years had DM at the
time of their colonoscopy, but 68 of these patients were
excluded due to poor or fair bowel preparation. Therefore, 125 patients ages 40-49 years with DM met study
eligibility criteria and were included in the study. We then
randomly selected 125 patients ages 40-49 years without DM and 125 patients ages 50-59 years without DM,
matching for date of exam and gender.
Baseline characteristics
Baseline characteristics of the three cohorts are found
in Table 1. Mean age was 46 years in the two younger
cohorts and 54 years in the older cohort. Gender was
matched for in all three cohorts with 63.2% female.
There was no difference in ethnicity among the three
cohorts with 35.2% African-Americans in the younger
cohort without DM, 46.0% with DM, and 39.2% in the
older cohort. There were significantly greater rates of comorbid obesity (higher mean BMI), hypertension, and hyperlipidemia in the cohort with DM as expected. Among
patients with DM, 77.7% were on oral hyperglycemic
medications, 52.3% were on insulin, and mean HgbA1C
was 7.4%.
Indication for colonoscopy was screening in 83% of
the patients ages 50-59 years without DM and 15% in the
younger cohorts. Nearly all of the screening colonoscopies in the younger cohorts were performed in patients
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The prevalence of high risk state, defined as adenoma
size ≥ 1 cm, presence of high grade dysplasia or villous
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Table 2 Polyp and adenoma detection rates
40-49 yr
without DM
(n = 125)

Table 3 Prevalence of high risk state
50-59 yr
40-49 yr
40-49 yr
with DM without DM
without DM
(n = 125) (n = 125) (n = 125)

50-59 yr
40-49 yr
with DM without DM
(n = 125) (n = 125)

Polyp detection rate (%)
31.2
49.6
Adenoma detection rate (%)
14.4
30.4
Univariate OR (95%CI)
1.0 (reference) 2.6 (1.4-4.9)
Multivariate OR (95%CI)1 1.0 (reference) 3.1 (1.5-6.4)

Prevalence of high risk state1
7.2
9.6
12.8
(%)
Univariate OR (95%CI)
1.0 (reference) 1.4 (0.6-3.4) 1.9 (0.8-4.5)
P = 0.5
P = 0.1

50.4
32.0
2.8 (1.5-5.2)
2.9 (1.5-5.6)

1

1

Analyses were adjusted for ethnicity, body mass index, smoking, and
alcohol use; DM: Diabetes mellitus.

High risk state was defined as adenoma number ≥ 3, size ≥ 1 cm, high
grade dysplasia, or villous features; DM: Diabetes mellitus.

these cohorts having significantly more adenomas than
those ages 40-49 years without DM. To our knowledge,
this is the first study to specifically examine these differences among patients with or without DM younger than
the recommended CRC screening age of 50 years.
In a large population-based retrospective cohort study,
Limburg et al[14] showed an association between DM and
increased CRC risk with a standardized incidence ratio of
1.39. Hu et al[15] also demonstrated a similar association
in the Nurses’ Health Study. After 18 years of follow-up,
relative risk for CRC was 1.43 in those with documented
DM at baseline. A recent meta-analysis by Yuhara et al[6]
found that DM was an independent risk factor for CRC
and was associated with an increased risk for CRC in
both men and women even after controlling for smoking,
obesity, and physical exercise with relative risk of 1.37.
Prior studies have also shown higher prevalence of
adenomas, the precursor to CRC, in patients with DM
compared to those without DM. In a prospective study,
Schoen et al[10] found an association between increased
levels of insulin and IGF-1 and presence of colorectal
adenomas as well as advanced adenomas in 458 asymptomatic patients who underwent flexible sigmoidoscopy.
Elwing et al[11] previously compared 100 women with DM
to 500 controls without DM undergoing index colonoscopy and found that women with DM had higher rates
of adenomas (37% vs 24%, OR = 1.82) and advanced
adenomas (14% vs 6%, OR = 2.38). With multivariate
analysis, they found that DM was an independent predictor for the presence of both adenomas and advanced
adenomas. Eddi et al[12] performed a retrospective casecontrol study of patients with or without adenomas and
found that DM, insulin exposure, and thiazolidinedione
use was associated with developing adenomas. More recently, Kanadiya et al[13] performed a retrospective crosssectional analysis of 405 patients with DM and 3038
without DM undergoing first colonoscopy. DM was associated with increased risk of adenoma (OR = 1.35) and
ADR was higher in diabetics (29.3% vs 23.9%). However,
none of these studies compared ADR in patients with or
without DM in patients under the age of 50 years.
There is consensus among guidelines that CRC
screening should be initiated in average-risk individuals starting at 50 years of age[2-4]. The rationale for this
threshold is that the risk of CRC and advanced adenomas
is low in younger individuals. The reported incidence of

Table 4 Polyp characteristics among patients with adenomas
(n = 96)
40-49 yr 40-49 yr 50-59 yr P -value
without DM with DM without DM
(n = 18) (n = 38) (n = 40)
Number of adenomas
(mean)
Location (% proximal)
Advanced adenoma (%)
Size ≥ 1 cm (%)
Villous features (%)
High grade dysplasia
(%)

1.5

1.7

1.5

0.69

38.9
50.0
33.3
27.8
0

55.3
31.6
18.4
13.2
2.6

52.5
40.0
32.5
15.0
2.5

0.50
0.40
0.30
0.36
0.79

DM: Diabetes mellitus.

features, or number of adenomas ≥ 3 in the three cohorts are found in Table 3. Prevalence of high risk state
were 7.2% in those ages 40-49 years without DM (10.9%
in men, 5.1% in women), 9.6% in those ages 40-49 with
DM (10.9% in men, 8.9% in women), and 12.8% in those
ages 50-59 years without DM (15.2% in men, 11.4% in
women). Compared to those ages 40-49 years without
DM, we found trends towards higher prevalence of high
risk state in those ages 40-49 years with DM and those
ages 50-59 years without DM, but these were not statistically significant. There was no statistically significant difference between the prevalence of high risk state in those
ages 40-49 years with DM and those ages 50-59 years
without DM (P = 0.4).
Polyp characteristics
Among patients with adenomas, mean number of adenomas per patient, location of adenomas, and prevalence
of advanced adenomas were not statistically significant
among the three cohorts (Table 4). There were one, zero,
and two synchronous CRC found in the cohorts ages
40-49 years without DM, ages 40-49 years with DM, and
ages 50-59 years without DM, respectively.

DISCUSSION
In this retrospective cohort study, DM was associated
with a significantly higher risk of developing colorectal
adenomas in patients ages 40-49 years. These subjects
harbored as many adenomas as those at the standard
screening age of 50-59 years without DM, with both of

WJG|www.wjgnet.com

6949

June 14, 2014|Volume 20|Issue 22|

Vu HT et al . Colorectal adenomas in younger patients

CRC per 100000 population rises from 45.9 at age 40-49
years, to 133.3 at age 50-59 years and 268.2 at age 60-69
years[16]. In two screening colonoscopy studies performed
in asymptomatic patients ages 40-49, the prevalence
of advanced adenomas was found to be 2% and 3.5%
with no cases of CRC[17,18]. The evidence from our study
shows that the existence of DM in patients ages 40-49
years increases their risk of adenomas and advanced adenomas to that of patients ages 50-59 years without DM.
Greater DM severity as determined by the need for
insulin therapy and HgbA1C levels, a measure of DM
control, has also been found to be associated with increased risk for both CRC as well as adenomas. In a prospective population study, Khaw et al[19] reported a threefold risk for CRC in known diabetics. In addition, they
found that there was a 1.34 increase in relative risk with
every 1% increase in HgbA1C concentrations. Yang et
al[20] demonstrated a two-fold increased risk of CRC in
patients with DM on insulin therapy for greater than one
year compared to non-insulin using patients with DM.
Chung et al[21] found that diabetic patients with adenomas
showed significantly higher rates of chronic insulin therapy compared to age and sex-matched controls, and that
chronic insulin therapy was associated with three times
the risk of having colorectal adenomas among a cohort
of 325 patients with DM who underwent colonoscopy.
Siddiqui et al[22] found that poorly controlled diabetics
with HgbA1C ≥ 7.5% had greater number of adenomas,
more advanced lesions, greater use of exogenous insulin,
and younger age of presentation in a retrospective cohort study of 652 male veterans with DM and adenomas.
In our cohort with DM, 52% were on chronic insulin
therapy and mean HgbA1C was 7.4, implying that at least
half of our patients with DM qualified as having severe
disease and were at higher risk for adenomas despite their
relatively young age.
Our study had several limitations. It was a retrospective cohort study with inherent limitations in this design
study. To date, there have been no reported prospective
studies evaluating the development of adenomatous
polyps in patients with DM or specifically those younger
than the age of 50 years. There was also a relatively low
sample size in each of the cohorts, likely due to low rates
of diabetes in patients 40-49 years old. Another limitation
of our study is that it was not performed in an average
risk screening population. However, patients under the
age of 50 years are currently not recommended to undergo screening colonoscopy unless they are at increased risk
for CRC. The only way to establish risk in this younger
population would be to design a prospective study of
asymptomatic, average-risk young patients with and without DM to compare risk of adenomas and CRC. Prior
published studies have also encountered this limitation.
In a recent study by Gupta et al[23] asymptomatic patients
aged 40-49 years undergoing screening for a family history of polyps were compared to a control population of
40-49 years olds with symptoms. In addition, longitudinal
studies following patients with DM over time would be
needed to study more clinically significant outcomes such
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as incidence of CRC and related mortality to address
whether the increase in number of adenomas found in
patients with DM leads to higher rates of CRC and related mortality. Such a study would require at least ten years
of follow-up to answer these questions. In the meantime,
retrospective cohort studies such as ours are the only
means to examine a younger population of diabetics.
The same may be said for studies evaluating the increased
CRC risk for African Americans, in which no prospective
studies have been performed. However, those retrospective studies have accumulated enough evidence to change
the American College of Gastroenterology guidelines
to recommend initiating CRC screening earlier at age 45
years[4,24].
Our study controlled for age, gender, and date of
procedure by design. Males have been established to
have higher risk for CRC and adenomas[1,25]. Dates of
procedures were controlled to take into account different endoscopists and to decrease accrual bias. Although
we adjusted our analyses by ethnicity, tobacco, alcohol,
and BMI, our study did not control for additional possible confounding risk factors such as diet and exercise.
There were higher rates of African-Americans in the DM
cohort, but this did not reach statistical significance and
ethnicity was adjusted for in the multivariate analysis. A
prior study by He et al[26] demonstrated increased risk of
CRC associated with DM (RR 1.19), which was consistent across four ethnic populations including Caucasians,
African-Americans, Japanese-Americans, and Latinos in a
prospective analysis of the population-based Multiethnic
Cohort. The other variables that were significantly different among our three cohorts are to be expected: age
(which was a defining feature of the cohorts) as well as
co-morbidities known to be associated with DM (obesity,
hypertension, and hyperlipidemia). However, the ADR
differences in the three cohorts still remained significant
after multivariate analysis adjusted for the presence of
ethnicity, BMI, smoking, and alcohol use.
In our study, we noted that the bowel preparation was
poor or fair in one-third of patients with DM, causing
their exclusion from the cohort. Diabetic patients may
have inadequate bowel preparation due to autonomic
neuropathy and gastrointestinal dysmotility associated
with their DM. This may lead to decreased detection of
both adenomas and CRC in patients with DM, since bowel
preparation is vital to high-quality screening colonoscopy.
If pre-malignant polyps are less frequently detected and
removed in diabetic patients due to inadequate visibility,
this may lead to the development of more interval CRC
in these patients. In addition, decreased detection of both
adenomas and CRC may lead to the underestimation of
their risk in those with DM. At our institution, we are
recommending that patients with DM undergo a more
stringent bowel preparation to ensure adequate visibility
and effective screening.
Our data may have important public health implications given the estimated 25.8 million people affected by
DM with rapidly rising incidence in the United States[27].
Other studies have suggested that DM increases the risk
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for development of CRC and adenomatous polyps, the
pre-malignant precursor to CRC. Our study confirms
this increased risk in patients with DM who were up to
a decade younger than the recommended screening age
of 50 years. These findings need to be validated in further studies, optimally with prospective and longitudinal
studies in younger diabetics that are asymptomatic and at
average risk for CRC. If our results are corroborated, this
high risk group may be targeted for more aggressive CRC
screening.
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